This PubMed entry references a free article published in Eur J Cancer in 2026 (Eur J Cancer. 2026 Aug 26:244:116925; Epub 2026 Jul 4) with PubMed PMID 42419148 and DOI 10.1016/j.ejca.2026.116925. The article is indexed as a free article on PubMed and provides links to full-text options. The title of the paper is Evidence for early, clinically silent medial temporal lobe inflammation after CAR-T cell therapy.
The article lists Marwa Al Dubai and a multidisciplinary team as authors. Affiliations reported on the PubMed page include multiple departments and centers at Otto von Guericke University Magdeburg and partner institutions, specifically Departments of Neurology; Hematology, Oncology, Cell Therapy, and Radiation Therapy; Institute for Clinical Immunology and Cell Therapeutics; Biomedical Magnetic Resonance; Neuroradiology; and affiliated centers such as the German Center for Neurodegenerative Diseases (DZNE), Center for Behavioral Brain Sciences (CBBS), Fraunhofer Institute for Cell Therapy and Immunology, and the Magdeburg Center for Cell and Immune Therapy (MAZI). The list indicates collaborative input from neurology, neuroradiology, immunology/cell therapy, and biomedical magnetic resonance groups.
The title reports evidence for early, clinically silent inflammation of the medial temporal lobe occurring after CAR-T cell therapy. The phrase clinically silent indicates that the inflammation referenced in the title was not associated with overt neurological symptoms at the time it was detected. The title asserts a temporal relationship between receipt of CAR-T cell therapy and detection of inflammation in the medial temporal lobe, described as an early finding.
The PubMed record indicates the article is a free article and provides a DOI link as well as full-text links on the PubMed page. Readers interested in the study's methods, imaging modalities, participant characteristics, quantitative findings, timing relative to CAR-T dosing, biomarkers, clinical monitoring, and outcomes should consult the full-text article via the DOI or journal site. The PubMed entry furnished here includes citation and author information but does not reproduce the article body.
Present in the supplied PubMed content:
Not reported in the supplied PubMed content (details that are absent from this PubMed summary and therefore cannot be summarized here):
Because these core elements are not included in the PubMed snippet presented here, they cannot be restated or interpreted beyond noting their absence. The title conveys the principal observation but does not substitute for source data.
The title alone suggests that clinicians and investigators administering or following patients after CAR-T cell therapy may encounter subclinical central nervous system findings, specifically early inflammation localized to the medial temporal lobe. The use of the term clinically silent implies detection by objective measures rather than by neurological symptoms. However, the PubMed entry provided does not supply the study's data or conclusions, so any discussion of clinical protocols, monitoring strategies, patient selection, diagnostic thresholds, or management responses would be speculative unless derived from the full text.
For accurate translation of the reported observation into practice or research planning, readers should review the full article for the study population, diagnostic approach, timing of assessments after CAR-T administration, the strength of association, and any reported recommendations. The multidisciplinary author list suggests contributions from neuroimaging, neurology, and hematology/oncology teams, which may inform the study methods and interpretation; again, specifics must be obtained from the full article.
Note on source limitations
This summary strictly reflects the information present on the supplied PubMed page. The PubMed entry provides metadata and the article title but does not include the abstract or main text in the extracted content used here. Where details required to inform clinical decisions or guideline development are missing, the full text should be consulted. Any assertions beyond the article title and bibliographic information are intentionally omitted because they were not reported in the supplied source content.